- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Solara Active Pharma Sciences announced that the funds from its recent Rights Issue have been utilized as planned, with no deviation for the recent quarter. From the ₹149.49 crores received via the first call, ₹138.27 crores has been deployed. The remaining ₹0.26 crores in the escrow account and ₹10.96 crores in the monitoring account will be used in upcoming quarters. The Audit Committee reviewed this statement and found no issues. This confirms the company is responsibly deploying capital raised to reduce borrowings and for general corporate purposes, aligning with shareholder expectations.
All announcements from Solara Active Pharma Sciences Limited